Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region
Facing the availability of the new generation of quadrivalent meningococcal conjugate vaccines (Menveo®, Menactra® and others pending for license) and their recent implementation in Saudi Arabia, experts from 11 countries of the Middle East region met at a "Meningococcal Leadership Forum"...
Saved in:
Main Authors: | Atef Shibl (Author), Haysam Tufenkeji (Author), Mohamed Khalil (Author), Ziad Memish (Author) |
---|---|
Format: | Book |
Published: |
Springer,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Invasive meningococcal disease and travel
by: Ziad A. Memish, et al.
Published: (2010) -
National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease
by: Cynthia Burman, et al.
Published: (2023) -
Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
by: Anand P. Dubey, et al.
Published: (2022) -
Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East
by: Ali S, et al.
Published: (2023) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is Not Circulating Among Hajj Pilgrims
by: Jaffar A. Al-Tawfiq, et al.
Published: (2023)